5031
|
|
|
GRB2 associated regulator of MAPK1 subtype 2 |
FAM59B, GAREML |
|
5032
|
|
|
Golgi associated RAB2 interactor family member 2 |
C14orf54, FAM71D, GARI-L1, GARI-L2 |
|
5033
|
|
|
Golgi associated RAB2 interactor family member 3 |
FAM71B, GARI-L3 |
|
5034
|
|
|
Golgi associated RAB2 interactor family member 4 |
FAM71A, GARI-L4, GARIL4 |
|
5035
|
|
|
Golgi associated RAB2 interactor 5A |
FAM71E1, GARIL5 |
|
5036
|
|
|
GTPase activating Rap/RanGAP domain like 3 |
bA356B19.1 |
|
5037
|
|
|
Granule associated Rac and RHOG effector 1 |
KIAA0355, MiniBAR |
|
5038
|
|
|
Glycyl-tRNA synthetase 1 |
CMT2D, DSMAV, GARS, GlyRS, HMN5, HMN5A, HMND5, SMAD1, SMAJI |
Charcot-marie-tooth disease, Distal hereditary motor neuropathy, Congenital pes cavus, Dejerine-sottas disease, Distal spinal muscular atrophy, Hereditary motor and sensory neuropathies, Motor neuron disease, Hypertrophic neuropathy, Peroneal muscle atrophy, Roussy-levy syndrome, Spinal muscular atrophy |
5039
|
|
|
Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
AIRS, GARS, GARTF, PAIS, PGFT, PRGS |
|
5040
|
|
|
Growth arrest specific 1 |
- |
|